Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Ocular Therapeutix Stock News

OCULNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$7.62

-0.52-6.39%

After Hours: 8:59 AM EDT

Ocular Therapeutix (OCUL) Forecast

News

Earnings Ocular Therapeutix (OCUL) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Ocular Therapeutix Stock News | NASDAQ:OCUL | Benzinga

Get the latest news on Ocular Therapeutix stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Ocular Therapeutix performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, May 29, 2025

Demystifying Ocular Therapeutix: Insights From 7 Analyst Reviews
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Ocular ...
Benzinga Newsdesk

Wednesday, May 28, 2025

Ocular Therapeutix shares are trading higher ...
Benzinga Newsdesk
Ocular Therapeutix Announced That Enrollment ...
Benzinga Newsdesk

Tuesday, May 20, 2025

10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights

Tuesday, May 06, 2025

Analyst Expectations For Ocular Therapeutix's Future
Benzinga Insights
Needham Maintains Buy on Ocular Therapeutix, ...
Benzinga Newsdesk

Monday, May 05, 2025

Ocular Therapeutix (OCUL) Stock Drops 13% After Q1 Earnings
Henry Khederian
Ocular Therapeutix shares are trading lower a...
Benzinga Newsdesk
Ocular Therapeutix Q1 EPS $(0.38) Misses $(0....
Benzinga Newsdesk
Earnings Scheduled For May 5, 2025
Benzinga Insights

Tuesday, April 08, 2025

Expert Outlook: Ocular Therapeutix Through The Eyes Of 5 Analysts
Benzinga Insights
This Weyerhaeuser Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Avi Kapoor
William Blair Initiates Coverage On Ocular Th...
Benzinga Newsdesk
Needham Reiterates Buy on Ocular Therapeutix,...
Benzinga Newsdesk

Tuesday, March 18, 2025

What 4 Analyst Ratings Have To Say About Ocular Therapeutix
Benzinga Insights
RBC Capital Initiates Coverage On Ocular Ther...
Benzinga Newsdesk

Tuesday, March 11, 2025

Ocular Therapeutix Axpaxli Advances In Phase 3 For Wet AMD, Analyst Forecasts Huge Upside
Vandana Singh
Ocular Therapeutix shares are trading higher ...
Benzinga Newsdesk
This Primoris Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Avi Kapoor
Needham Initiates Coverage On Ocular Therapeu...
Benzinga Newsdesk

Tuesday, March 04, 2025

Citizens Capital Markets Maintains Market Out...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Ocular ...
Benzinga Newsdesk

Monday, March 03, 2025

Ocular Therapeutix shares are trading lower a...
Benzinga Newsdesk
Ocular Therapeutix Expects Cash Balance Of $3...
Benzinga Newsdesk
Ocular Therapeutix Q4 2024 GAAP EPS $(0.29) M...
Benzinga Newsdesk
Earnings Scheduled For March 3, 2025
Benzinga Insights

Tuesday, January 14, 2025

Ocular Therapeutix Showcases Progress on AXPA...
Benzinga Newsdesk

Monday, January 13, 2025

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights

Tuesday, December 03, 2024

Expert Outlook: Ocular Therapeutix Through The Eyes Of 4 Analysts
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Ocular ...
Benzinga Newsdesk

Monday, December 02, 2024

Ocular Therapeutix Announced That More Than 3...
Benzinga Newsdesk

Friday, November 15, 2024

HC Wainwright & Co. Maintains Buy on Ocular T...
Benzinga Newsdesk

Thursday, November 14, 2024

Ocular Therapeutix's Cash Balance Of $427.2M ...
Benzinga Newsdesk
Ocular Therapeutix Q3 2024 GAAP EPS $(0.22) B...
Benzinga Newsdesk
Earnings Scheduled For November 14, 2024
Benzinga Insights

Wednesday, November 13, 2024

A Peek at Ocular Therapeutix's Future Earnings
Benzinga Insights

Wednesday, October 16, 2024

Ocular Therapeutix shares are trading higher ...
Benzinga Newsdesk
Scotiabank Initiates Coverage On Ocular Thera...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Ocular ...
Benzinga Newsdesk

Tuesday, October 15, 2024

Ocular Therapeutix Fast-Tracks SOL-1 Registra...
Benzinga Newsdesk

Thursday, August 08, 2024

Baird Maintains Outperform on Ocular Therapeu...
Benzinga Newsdesk

Wednesday, August 07, 2024

Ocular Therapeutix' Cash Balance Of $459.7M A...
Benzinga Newsdesk
Ocular Therapeutix Q2 2024 GAAP EPS $(0.26) M...
Benzinga Newsdesk
Ocular Therapeutix Has Received FDA Written R...
Benzinga Newsdesk

Thursday, August 01, 2024

Beyond The Numbers: 8 Analysts Discuss Ocular Therapeutix Stock
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Ocular ...
Benzinga Newsdesk

Tuesday, July 30, 2024

Ocular Therapeutix Enrolls First Patients In ...
Benzinga Newsdesk

Wednesday, July 10, 2024

Ocular Therapeutix To Present Late-Breaking A...
Benzinga Newsdesk

Friday, June 21, 2024

Piper Sandler Maintains Overweight on Ocular ...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved